Our results showed that both a PKC inhibitor and a ROCK inhibitor inhibited approximately 50% of WNT5A-induced MARCKS phosphorylation in A2058 (Figure 6A,B) and A375 (Figure S5A,B) melanoma cells compared to the vehicle-stimulated controls. Here, PRRT2 is linked to melanoma.